Market Overview

Global Nephrology and Urology Devices Market Analysis & Forecasts, 2018-2024: Key Players are Baxter International, Fresenius Medical Care, Boston Scientific & C.R. Bard


Global Nephrology and Urology Devices Market Analysis & Forecasts, 2018-2024: Key Players are Baxter International, Fresenius Medical Care, Boston Scientific & C.R. Bard

PR Newswire

DUBLIN, Aug 31, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024" report has been added to's offering.

The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024, exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth.

This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices.

Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disintegration and extraction, and extracorporeal shockwave lithotripsy, are anticipated to boost the market over the forecast period. Furthermore, presence of highly advanced pipeline products such as bioartificial kidney is presumed to present the market with lucrative growth opportunities in future.

Increase in demand for minimally invasive techniques is also likely to propel the market in the coming years. Nephrology and urology devices facilitate early diagnosis and shorter treatment duration in most surgical procedures. Minimal pain, heightened cost efficiency, safety, efficacy, rapid recovery, and reduced hospital stay are other benefits offered by these devices. This is expected to boost adoption over the forecast period.

Further key findings from the report suggest:

  • The global urology segment is anticipated to reach USD 21.4 billion by 2024, at a CAGR of 6.9% from 2016 to 2024
  • By type, the benign prostatic hyperplasia segment is anticipated to witness lucrative growth over the forecast period
  • Europe held the dominant revenue share as of 2015 owing to a large target population. Growth across this region is primarily driven by presence of prominent market players implementing extensive expansion strategies such as product development and mergers and acquisitions
  • Asia Pacific, especially countries such as India and China, is expected to observe remarkable growth in the coming years
  • The global industry is dominated by few players and is marked by extensive new product development and high-end investments in R&D. Level of competition is expected to remain high over the forecast period
  • Some of the key players in the market are Baxter International, Inc.; Fresenius Medical Care AG & Co. KGaA; Boston Scientific; and C.R. Bard Inc.

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources

Chapter 2. Executive Summary

Chapter 3. Market Snapshot

Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & growth prospect mapping
4.5. Nephrology and urology Competitive Landscape, 2015
4.5.1. Company market share analysis
4.5.2. Competitive landscape: market position analysis
4.6. Nephrology and urology devices-SWOT Analysis, By Factor (political & legal, economic and technological)
4.7. Industry Analysis - Porter's

Chapter 5. Type Estimates & Trend Analysis
5.1. Nephrology and urology devices Market: Type movement analysis
5.2. Dialysis
5.3. Urinary Stone
5.3.1. Urinary stone market estimates and forecasts, 2013 - 2024 (USD Billion)
5.3.2. Ureteral Stents
5.3.3. Lithotripters
5.4. Urinary Incontinence & Pelvic Organ Prolapse
5.4.1. Urinary incontinence & pelvic organ prolapse market estimates and forecasts, 2013 - 2024 (USD Billion)
5.4.2. Sacral Neuromodulation
5.4.3. Vaginal Meshes & Slings
5.4.4. Urethral Inserts & Pessaries
5.5. Benign Prostatic Hyperplasia
5.5.2. Catheter Ablation
5.5.3. Prostatic Stents
5.5.4. Endoscopy
5.5.5. Others

Chapter 6. Regional Estimates & Trend Analysis, By Type

Chapter 7. Competitive Landscape

  • Asahi Kasei Corporation
  • B.Braun Group
  • Baxter International, Inc
  • Boston Scientific Corporation
  • C.R. Bard, Inc
  • Coloplast AS
  • Cook Medical
  • Dornier MedTech
  • Fresenius Medical Care AG & Co. KGaA
  • Nikkiso Co.Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Olympus Medical Systems
  • Rockwell Medical Technologies, Inc.
  • Terumo Corporation
  • Svenska Cellulosa Aktiebolaget (SCA)
  • ONTEX International N.V.
  • Kimberly-Clark Corporation
  • First Quality Enterprises, Inc.
  • Teleflex Incorporated
  • Siemens Healthineers
  • Medtronic
  • Medline Industries, Inc.
  • STORZ Medical AG

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Cision View original content with multimedia:

SOURCE Research and Markets

View Comments and Join the Discussion!